| 2012 | ADDITIONAL GENOMIC ABERRATIONS IDENTIFIED BY SNP-ARRAY BASED KARYOTYPING IN CASES WITH ISOLATED DEL(9Q) OR DEL(20Q) ABNORMALITY | 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2015 | Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome | 문영철 | Article |
| 2015 | Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia | 정화순; 성주명; 허정원; 문영철; 정혜선 | Article |
| 2009 | Cancer of Unknown Primary Finally Revealed to Be a Metastatic Prostate Cancer: A Case Report | 이순남; 성주명; 이경은; 송동은 | Article |
| 2007 | CD34, RAB20, DLK1, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2018 | Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma | 성주명; 허정원; 문영철 | Article |
| 2021 | Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia | 이미애; 성주명; 허정원; 문영철; 박영미; 정혜선; 박설희; 김이준 | Article |
| 2018 | GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms | 이미애; 성주명; 허정원; 조민선; 문영철 | Article |
| 2012 | Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome | 문영철 | Meeting Abstract |
| 2015 | Manipulation of beta-catenin pathway to overcome endocrine resistance in breast cancer. | 이순남; 성주명; 이경은; 문영철; 남은미 | Meeting Abstract |
| 2006 | Prognostic significance of CD44s expression in bile duct carcinomas | 이순남; 성주명; 조민선; 이경은; 문영철 | Meeting Abstract |
| 2017 | VARIABLE NATURAL KILLER CELL ACTIVITY IN HEMATOLOGIC MALIGNANCIES AT DIAGNOSIS | 성주명; 허정원; 문영철 | Meeting Abstract |
